Jump to content [Access key 'm'] Jump to site navigation [Access key 'n'] Jump to Contact Us and Glossary [Access key 's'] Jump to Site Services and Sitemap [Access key 's'] Jump to local navigation [Access key 'l']
 

Investors

Press Releases

If you would like to be alerted when a press release is added to this site, please register with the Alerting Service.



 

08/13/2010 Cyclacel Pharmaceuticals’ 6% convertible exchangeable preferred stockholders request special meeting to elect directors
08/05/2010 Cyclacel Pharmaceuticals reports second quarter 2010 financial results
07/29/2010 Cyclacel Pharmaceuticals to announce release of second quarter 2010 financial results
07/01/2010 Cyclacel Pharmaceuticals announces FDA orphan drug designation for sapacitabine in both AML and MDS
06/28/2010 Cyclacel Pharmaceuticals added to Russell Microcap Index
06/18/2010 Cyclacel answers Celgene’s declaratory judgment complaint and counterclaims for infringement of four Cyclacel patents
06/07/2010 Cyclacel reports interim Phase 2 sapacitabine data in myelodysplastic syndromes at 2010 ASCO annual meeting
05/21/2010 Cyclacel Pharmaceuticals to report new sapacitabine Phase 2 interim results in MDS at the American Society of Clinical Oncology Annual Meeting
05/13/2010 Cyclacel Pharmaceuticals reports financial results for first quarter 2010
05/13/2010 Cyclacel to restate 2009 annual financial statements to correct net loss per share
1  2  3    >>
Go to top  Go to top    Print page (opens in a new window)  Print page
 
Copyright © 1997-2009 Cyclacel Pharmaceuticals, Inc. All Rights Reserved  |  Site Map  |  Privacy  |  Disclaimer  |  Contact Us  |  Alerting Service